Korean digital health company LifeSemantics has obtained the first approval for an AI-powered solution for skin cancer diagnosis in South Korea.The company received regulatory clearance from the Ministry of Food and Drug Safety for…
Continue Reading
What You Should Know:
– A glimmer of hope emerged today for rectal cancer patients as a collaborative effort between Case Western Reserve University (CWRU), Cleveland Clinic, and University Hospitals (UH) received a $2.78 million…
Continue Reading
Lila, alongside her mom Nicole in 2022
What You Should Know:
– Amazon Web Services (AWS) announced a significant $10M commitment to propel research for pediatric healthcare and unlock a deeper understanding of rare childhood diseases.
–…
Continue Reading
Artificial intelligence tools are helping primary care doctors diagnose skin cancer, home care providers retain employees and hospital doctors get early warnings about potential patient mental health episodes in stories we’re reading this week. Solventum…
Continue Reading
What You Should Know:
– Merck Global Health Innovation Fund (MGHIF), a leader in healthcare impact investing, announced a strategic investment in Qure.ai, a prominent developer of artificial intelligence (AI) solutions for medical imaging.
– The…
Continue Reading
By Anuja Vaidya
June 25, 2024 – Radiation oncology treatment provided via telehealth is associated with high patient satisfaction and safety and substantial cost savings, according to research published in JAMA Network Open.
The study assessed Memorial…
Continue Reading
More than 1,134 elective procedures and 2,194 outpatient appointments have been postponed at King’s College Hospital NHS Foundation Trust and Guy’s and St Thomas’ NHS Foundation Trust since a cyber attack on 3 June…
Continue Reading
Raman Parthasarathy, Business Unit Head, Fusemachines
Of the many industries witnessing AI-led transformation, healthcare happens to be one. Today, AI’s promise in healthcare extends beyond automation-led operational and administrative efficiencies. It’s beginning to show a…
Continue Reading
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment of non-csPCa. Early identification…
Continue Reading
What You Should Know:
– Today, GE HealthCare (Nasdaq: GEHC) and MediView XR Inc. announced the successful launch of the OmnifyXR Interventional Suite, marking the first-ever clinical use of this innovative augmented reality (AR) technology.
–…
Continue Reading
